Veeva Systems Inc. (VEEV) stock analysis

Healthcare · Health Information Services

From the 10-K filed 2026-03-20

How it makes money

Subscription fees from R&D and Quality Solutions provide 53% of subscription revenue, driven by life sciences companies managing clinical trials and regulatory submissions.

It generates 55% of total revenue from R&D and Quality Solutions, which include the Veeva Vault platform for clinical trial execution, regulatory information management, and safety data. The remaining 45% comes from Commercial Solutions, including the next-generation Vault CRM and data products like Veeva Compass.

Life sciences companies pay subscription fees for these tools because they consolidate siloed data and automate compliance with healthcare authorities. Subscription revenue accounts for 84% of the total, with growth driven by the number of active users and the adoption of additional applications within its four main cloud suites.

What could damage it

The forced migration of its legacy CRM customers to the proprietary Vault CRM platform by 2029 risks driving users to competitors like Salesforce.

It is currently moving its CRM customer base from a platform provided by Salesforce to its own Vault CRM. This migration could cause business disruptions that lead customers to evaluate rival solutions from Salesforce or IQVIA.

Since its revenue is highly concentrated in the life sciences industry, any regulatory shift that reduces global drug pricing or pharmaceutical marketing spending would attack its primary earnings base. Loss of one or more key customers among the global pharmaceutical giants would also cause a material decline in revenue.

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

More on VEEV

Other companies in Health Information Services